UK launch for Alliance’s pregnancy anti-nausea and vomiting drug
Alliance Pharma has announced the launch of Xonvea in the UK to treat nausea and vomiting of pregnancy (NVP) in women who do not respond to conservative management.
Read More
Tag: Alliance Pharma
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
